Zika Virus in Nepal — Risk, Testing & Pregnancy Guidance Transmission, Symptoms, Testing & the Pregnancy Risks That Matter

What Zika Is and Why It Matters

Zika is a mosquito-borne virus in same family as dengue — transmitted primarily by Aedes mosquitoes ( same vector as dengue, which circulates seasonally in Nepal) and also sexually, from person to person, for weeks to months after infection.

For most adults Zika is mild: roughly 80% of infections are completely asymptomatic, and symptomatic cases are typically a brief, self-limited illness — low fever, rash, conjunctivitis, joint pain — resolving over about a week. The serious risk is to pregnancy: infection during pregnancy can cause congenital Zika syndrome — severe fetal brain abnormalities including microcephaly — and this is reason Zika warrants attention even where adult illness is mild.

Zika is also relevant to sexual health services precisely because it is sexually transmissible — an infected partner can transmit to a pregnant partner even without mosquito exposure, which is why pregnancy-related guidance covers both partners.

How Zika Spreads

The main route is bite of an infected Aedes mosquito — day-biting mosquitoes common in tropical and subtropical areas including parts of Nepal. Because dengue circulates on same vector, Zika transmission is plausible wherever dengue is seasonal.

Sexual transmission is documented and clinically important: virus can persist in semen and vaginal fluids for weeks to months — longer in semen than in blood — and can be transmitted to a partner even when infected person has no symptoms. This makes Zika guidance directly relevant to sexual health consultations for couples planning or in pregnancy.

Symptoms & the Silent Majority

About 80% of Zika infections cause no symptoms at all. When symptoms occur — typically 3–14 days after exposure — they are usually mild: low fever, a spreading rash, red eyes (conjunctivitis), and joint or muscle pain, resolving over about a week without specific treatment.

The practical consequence of silent majority: absence of symptoms does not rule out infection. For a pregnant patient or a couple planning pregnancy, a relevant exposure — travel to an endemic area, or a symptomatic or travel-exposed partner — matters more than whether anyone felt ill.

Testing & Its Limitations

Zika testing depends heavily on timing: PCR detects virus during roughly first week of infection (longer in urine than blood); after that window, serology (IgM/IgG) is used — complicated by cross-reactivity with dengue and other flaviviruses, which can make results difficult to interpret in a dengue-endemic region like Nepal.

Testing is most clearly indicated for pregnant patients with relevant exposure, couples planning conception after a partner's travel to an endemic area, and symptomatic patients where distinguishing Zika from dengue changes management. For a non-pregnant, mildly symptomatic patient without pregnancy plans, testing often adds little — honest advice may be watchful waiting with prevention measures.

Pregnancy & Conception Guidance

The serious consequence of Zika is congenital: infection during pregnancy — particularly early pregnancy — can cause severe fetal brain abnormalities including microcephaly and other neurological damage. For pregnant patients with relevant exposure, assessment and where appropriate testing and ultrasound monitoring are indicated.

For couples planning pregnancy after a possible exposure, guidance covers both partners: precautions are advised for a period after a partner's travel to an endemic area ( recommended interval is longer for male partner because virus persists longer in semen). Mosquito avoidance and barrier protection during relevant window are practical measures.

Zika Assessment & Costs

Transparent pricing; confirm when booking.

Related Services & Guides